We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Ferrovial SE | EU:FER | Euronext | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.36 | -3.54% | 37.10 | 37.04 | 37.14 | 37.82 | 37.10 | 37.68 | 3,362 | 14:03:10 |
Hot Features
Premium
RNS Number:2074Z
Ferraris Group PLC
29 July 2002
FOR RELEASE 7.00 am 29 July 2002
Ferraris Group plc
Contract Gains
Ferraris Group plc, the medical technology group specialising in cardiac and
pulmonary diagnostics and components for MRI scanners, has been awarded two
contracts for clinical research trials worth a total of US$4.5mn. The work for
two leading pharmaceutical companies will start in 2003.
Ends
Background note:
Ferraris Group plc, is a leading manufacturer of user-friendly cardiac and
pulmonary diagnostic equipment as well as manufacturing components for MRI
scanners. Recently, the Collins Medical Division of the Company gained Food &
Drug Administration (FDA) approval for its Infant Pulmonary Laboratory, a unique
product which can measure the lung capability and capacity of infants as young
as four weeks of age.
Contact details:
FERRARIS GROUP PLC
Steven Mills (Chief Executive Officer) Tel: (0121) 782 6000
Mobile 07831 677 067
BINNS & CO PR LTD
Peter Binns / Paul McManus (020) 7786 9600
This information is provided by RNS
The company news service from the London Stock Exchange
1 Year Ferrovial Chart |
1 Month Ferrovial Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
